TLR9/HEK293 Stable Cell Line Preis auf Anfrage

Artikelnummer: ABI-14-538ACL
Artikelname: TLR9/HEK293 Stable Cell Line Preis auf Anfrage
Artikelnummer: ABI-14-538ACL
Hersteller Artikelnummer: 14-538ACL
Alternativnummer: ABI-14-538ACL-1VIAL
Hersteller: Abeomics
Kategorie: Zellen/Zellkultur
Applikation: FA
TLR9/HEK293 Stable Cell Line is a stably transfected HEK293 cell line which expresses human Toll-like receptor 9 (TLR9, also designated as CD289). TLR9 mediates immune responses by recognition of unmethylated CpGs of bacterial or viral origin, of which activation involves in various human diseases including systemic lupus erythematosus, erythema nodosum leprosum, inflammatory bowel disease, rheumatoid arthritis, sarcoidosis and Alzheimers disease. Sequence data: Human TLR9 (accession number NP_059138) MGFCRSALHPLSLLVQAIMLAMTLALGTLPAFLPCELQPHGLVN CNWLFLKSVPHFSMAAPRGNVTSLSLSSNRIHHLHDSDFAHLPSLRHLNLKWNCPPVG LSPMHFPCHMTIEPSTFLAVPTLEELNLSYNNIMTVPALPKSLISLSLSHTNILMLDS ASLAGLHALRFLFMDGNCYYKNPCRQALEVAPGALLGLGNLTHLSLKYNNLTVVPRNL PSSLEYLLLSYNRIVKLAPEDLANLTALRVLDVGGNCRRCDHAPNPCMECPRHFPQLH PDTFSHLSRLEGLVLKDSSLSWLNASWFRGLGNLRVLDLSENFLYKCITKTKAFQGLT QLRKLNLSFNYQKRVSFAHLSLAPSFGSLVALKELDMHGIFFRSLDETTLRPLARLPM LQTLRLQMNFINQAQLGIFRAFPGLRYVDLSDNRISGASELTATMGEADGGEKVWLQP GDLAPAPVDTPSSEDFRPNCSTLNFTLDLSRNNLVTVQPEMFAQLSHLQCLRLSHNCI SQAVNGSQFLPLTGLQVLDLSHNKLDLYHEHSFTELPRLEALDLSYNSQPFGMQGVGH NFSFVAHLRTLRHLSLAHNNIHSQVSQQLCSTSLRALDFSGNALGHMWAEGDLYLHFF QGLSGLIWLDLSQNRLHTLLPQTLRNLPKSLQVLRLRDNYLAFFKWWSLHFLPKLEVL DLAGNQLKALTNGSLPAGTRLRRLDVSCNSISFVAPGFFSKAKELRELNLSANALKTV DHSWFGPLASALQILDVSANPLHCACGAAFMDFLLEVQAAVPGLPSRVKCGSPGQLQG LSIFAQDLRLCLDEALSWDCFALSLLAVALGLGVPMLHHLCGWDLWYCFHLCLAWLPW RGRQSGRDEDALPYDAFVVFDKTQSAVADWVYNELRGQLEECRGRWALRLCLEERDWL PGKTLFENLWASVYGSRKTLFVLAHTDRVSGLLRASFLLAQQRLLEDRKDVVVLVILS PDGRRSRYVRLRQRLCRQSVLLWPHQPSGQRSFWAQLGMALTRDNHHFYNRNFCQGPT AE
Application Verdünnung: Application:. Functional assay. Culture conditions: Cells should be grown at 37oC with 5% CO2 using DMEM medium (w/ L-Glutamine, 4.5g/L Glucose and Sodium Pyruvate) supplemented with 10% heat-inactivated FBS and 1% Pen/Strep, plus 10 µg/ml of Blasticidin.